Physician profile
Matthew Eugene Phillips
NPI 1770671901
$1,896.86
in general payments reported to CMS, 2019-2025
30 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $43.13 · 2021: $551 · 2022: $294 · 2023: $198 · 2024: $240 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783 · Education: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.32 |
| Education | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.88 | 2019-2022 | |
| Hologic Sales and Service, LLC | $324.42 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Intuitive Surgical, INC. | $289.81 | 2021-2025 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $79.61 | 2023-2025 | |
| Evofem Biosciences, INC. | $78.30 | 2021-2022 | |
| Therapeuticsmd, INC. | $78.22 | 2019 | |
| Medtronic, INC. | $73.46 | 2021-2024 | Interstim |
| Amgen INC. | $53.23 | 2019-2021 | |
| Scynexis, INC. | $49.87 | 2021-2022 | |
| Radius Health, INC. | $48.37 | 2025 | Tymlos |
| Pfizer INC. | $46.34 | 2022-2025 | |
| Organon LLC | $44.01 | 2022-2024 | |
| Shield Therapeutics INC | $41.70 | 2024 | |
| Channel Medsystems, INC. | $34.20 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.38 | 2022-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $31.74 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $28.88 | 2020-2021 | |
| Dexcom, INC. | $28.85 | 2025 | Dexcom G6 Transmitter |
| Meditrina | $28.44 | 2024-2025 | |
| Astellas Pharma US INC | $16.78 | 2024 | Veozah |
| Mission Pharmacal Company | $16.16 | 2019 | |
| Agile Therapeutics, INC. | $15.59 | 2021 | |
| Minerva Surgical, INC | $15.51 | 2024 | |
| Monaghan Medical Corporation | $15.30 | 2023 | Aerobika |
| Novo Nordisk INC | $15.20 | 2025 | Wegovy |
| Avion Pharmaceuticals | $13.36 | 2022 | |
| Myovant Sciences INC. | $12.72 | 2021 | |
| Coloplast Corp | $12.42 | 2019 | |
| Exeltis, USA INC. | $11.14 | 2021 | |
| Vivus LLC | $10.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.